Literature DB >> 2029453

Genetic alterations in human gastric cancer.

S Hirohashi1, T Sugimura.   

Abstract

Most types of human tumors display a consistent set of genetic alterations that are thought to play a role in tumor development and progression. In the case of gastric carcinomas, consistent genetic changes have been difficult to identify because (1) the tumor DNA samples are often heavily contaminated with DNA from normal stromal cells and (2) the tumors are heterogeneous in origin. However, with the recent application of more refined molecular genetic techniques, it has become clear that gastric carcinomas display some of the same genetic alterations observed in other common carcinomas. These changes include point mutation of the ras oncogene and the p53 tumor suppressor gene, gene amplification, and chromosomal loss of heterozygosity.

Entities:  

Mesh:

Year:  1991        PMID: 2029453

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  12 in total

1.  Clinicopathological features of gastric carcinoma patients with other primary carcinomas.

Authors:  Young Kyu Park; Dong Yi Kim; Jae Kyoon Joo; Jung Chul Kim; Yang Suk Koh; Seong Yeob Ryu; Young Jin Kim; Shin Kon Kim
Journal:  Langenbecks Arch Surg       Date:  2004-12-15       Impact factor: 3.445

2.  TP53 gene mutations in gastric carcinoma detected by polymerase chain reaction/single-strand conformation polymorphism analysis of archival material.

Authors:  E D'Andrea; R Baffa; C Menin; M Montagna; M Rugge; L Chieco-Bianchi
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis.

Authors:  R Kushima; W Müller; M Stolte; F Borchard
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

4.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Decreased expression of DCC mRNA in gastric and colorectal cancer.

Authors:  M Kataoka; T Okabayashi; K Orita
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 6.  Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.

Authors:  Graciele Almeida de Oliveira; Robert Y S Cheng; Lisa A Ridnour; Debashree Basudhar; Veena Somasundaram; Daniel W McVicar; Hugo Pequeno Monteiro; David A Wink
Journal:  Antioxid Redox Signal       Date:  2016-10-31       Impact factor: 8.401

7.  Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.

Authors:  E Ricevuto; C Ficorella; C Fusco; K Cannita; A Tessitore; E Toniato; A Gabriele; L Frati; P Marchetti; A Gulino; S Martinotti
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

Review 8.  News of TNM and its use for classification of gastric cancer.

Authors:  P Hermanek; C Wittekind
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

9.  Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach.

Authors:  R Kushima; T Hattori
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  The effects of sodium chloride, miso or ethanol on development of intestinal metaplasia after X-irradiation of the rat glandular stomach.

Authors:  H Watanabe; T Okamoto; T Takahashi; P O Ogundigie; A Ito
Journal:  Jpn J Cancer Res       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.